tiprankstipranks
Advertisement
Advertisement

AU:LDX Stock Latest News

Lumos Wins Three-Year Manufacturing Deal for Micro-Pak Mold Analyzer
Company AnnouncementsLumos Wins Three-Year Manufacturing Deal for Micro-Pak Mold Analyzer
24h ago
LDX
Lumos Issues 5 Million New Shares on Option Exercise, Confirms Regulatory Compliance
PremiumCompany Announcements
Lumos Issues 5 Million New Shares on Option Exercise, Confirms Regulatory Compliance
7d ago
LDX
Lumos Diagnostics Seeks Quotation for 5 Million New ASX Shares
PremiumCompany Announcements
Lumos Diagnostics Seeks Quotation for 5 Million New ASX Shares
7d ago
LDX
Lumos Diagnostics to Brief Investors on FebriDx Clearance and Capital Raising
PremiumCompany Announcements
Lumos Diagnostics to Brief Investors on FebriDx Clearance and Capital Raising
13d ago
LDX
Lumos Diagnostics Launches A$20 Million Capital Raising via Placement and SPP
PremiumCompany Announcements
Lumos Diagnostics Launches A$20 Million Capital Raising via Placement and SPP
13d ago
LDX
Lumos Diagnostics Launches Securities Purchase Plan to Issue New Shares and Options
PremiumCompany AnnouncementsLumos Diagnostics Launches Securities Purchase Plan to Issue New Shares and Options
13d ago
LDX
Lumos Diagnostics Plans Major Share and Options Issue on ASX
Premium
Company Announcements
Lumos Diagnostics Plans Major Share and Options Issue on ASX
13d ago
LDX
Lumos raises capital to accelerate U.S. rollout of FebriDx after CLIA waiver
Premium
Company Announcements
Lumos raises capital to accelerate U.S. rollout of FebriDx after CLIA waiver
13d ago
LDX
Lumos Wins FDA CLIA Waiver for FebriDx, Unlocking US$1 Billion Market
PremiumCompany Announcements
Lumos Wins FDA CLIA Waiver for FebriDx, Unlocking US$1 Billion Market
13d ago
LDX
Lumos Diagnostics Halts Trading Ahead of Key FDA FebriDx Update
PremiumCompany Announcements
Lumos Diagnostics Halts Trading Ahead of Key FDA FebriDx Update
15d ago
LDX
Lumos Diagnostics Seeks ASX Quotation for Additional Shares
PremiumCompany Announcements
Lumos Diagnostics Seeks ASX Quotation for Additional Shares
1M ago
LDX
Lumos Diagnostics Signals Turning Point In Earnings Call
PremiumCompany Announcements
Lumos Diagnostics Signals Turning Point In Earnings Call
1M ago
LDX
Lumos Diagnostics Releases 1H FY26 Results Presentation and Hosts Investor Webinar
PremiumCompany AnnouncementsLumos Diagnostics Releases 1H FY26 Results Presentation and Hosts Investor Webinar
1M ago
LDX
Lumos Hits Key U.S. Milestones as FebriDx Push Accelerates
Premium
Company Announcements
Lumos Hits Key U.S. Milestones as FebriDx Push Accelerates
1M ago
LDX
Lumos Diagnostics’ Half-Year Loss Widens as Going-Concern Risks Mount
Premium
Company Announcements
Lumos Diagnostics’ Half-Year Loss Widens as Going-Concern Risks Mount
1M ago
LDX
Lumos Hits Paediatric Trial Milestone, Unlocks BARDA Funding for FebriDx Expansion
PremiumCompany Announcements
Lumos Hits Paediatric Trial Milestone, Unlocks BARDA Funding for FebriDx Expansion
2M ago
LDX
Lumos Diagnostics Issues New Shares on Employee Option Exercises, Affirms Compliance Ahead of Half-Year Report
PremiumCompany Announcements
Lumos Diagnostics Issues New Shares on Employee Option Exercises, Affirms Compliance Ahead of Half-Year Report
2M ago
LDX
Lumos Diagnostics Seeks Quotation of Additional 768,159 Shares on ASX
PremiumCompany Announcements
Lumos Diagnostics Seeks Quotation of Additional 768,159 Shares on ASX
2M ago
LDX
Lumos Diagnostics Issues Cautious Q2 FY26 Financial Presentation
PremiumCompany Announcements
Lumos Diagnostics Issues Cautious Q2 FY26 Financial Presentation
2M ago
LDX
Lumos Diagnostics Boosts FebriDx Sales as It Advances U.S. CLIA Waiver and Secures Full Medicare Reimbursement
PremiumCompany AnnouncementsLumos Diagnostics Boosts FebriDx Sales as It Advances U.S. CLIA Waiver and Secures Full Medicare Reimbursement
2M ago
LDX
Lumos Wins Follow-On Contract to Lead FDA-Bound Trial for Aptatek’s PKU Device
Premium
Company Announcements
Lumos Wins Follow-On Contract to Lead FDA-Bound Trial for Aptatek’s PKU Device
3M ago
LDX
Lumos Diagnostics Issues New Shares on Option Exercises, Confirms Regulatory Compliance
Premium
Company Announcements
Lumos Diagnostics Issues New Shares on Option Exercises, Confirms Regulatory Compliance
3M ago
LDX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >